Announcement on the Interest Payment of Baiyang Convertible Bonds in 2026
Qingdao Baiyang Pharmaceutical Co., Ltd. and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- The "Baiyang Convertible Bonds" (bond code: 123194) will pay the third-year interest at face value on April 14, 2026. The interest for every 10 bonds (face value RMB 1,000) is RMB 10.00 (tax included).
- Interest entitlement registration date: April 13, 2026 (Monday)
- Ex-dividend date: April 14, 2026 (Tuesday)
- Interest payment date: April 14, 2026 (Tuesday)
- The interest period and coupon rate: The interest period is from April 14, 2025, to April 13, 2026, with a coupon rate of 1.00%.
- The interest entitlement registration date for this payment is April 13, 2026. Holders of "Baiyang Convertible Bonds" registered with China Securities Depository and Clearing Corporation Limited Shenzhen Branch (hereinafter referred to as "China Clearing Shenzhen Branch") after the market closes on April 13, 2026, will enjoy the interest distribution. Holders who apply for conversion into shares of Qingdao Baiyang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") before or on April 13, 2026, will not receive interest for this and subsequent interest periods.
- The next interest period start date: April 14, 2026
- The next interest period coupon rate: 1.50%
According to the approval from the China Securities Regulatory Commission regarding the registration of the issuance of convertible bonds by Qingdao Baiyang Pharmaceutical Co., Ltd. (Zheng Jian Xu Ke [2023] No. 613), the Company issued 8,600,000 convertible bonds at a face value of RMB 100 each on April 14, 2023, raising a total of RMB 860 million. With the approval of the Shenzhen Stock Exchange, the convertible bonds were listed for trading on May 5, 2023, under the name "Baiyang Convertible Bonds" and bond code "123194."